Price (delayed)
$110.04
Market cap
$2.01B
P/E Ratio
45.1
Dividend/share
N/A
EPS
$2.44
Enterprise value
$2B
Ligand Pharmaceuticals is a biopharmaceutical company located in San Diego, California. Founded in 1987 as Progenx Inc., the company went public in 1992.
There are no recent dividends present for LGND.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.